PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-09-08

Date Title Company
08-Sep-2020 Dupixent® (dupilumab) Long-term Data Show Sustained Improvement in Lung Function and Reduction in Severe Exacerbations in Adults and Adolescents with Moderate-to-severe Asthma Regeneron Pharmaceuticals, Inc.